Osvaldo Flores - 17 Jun 2021 Form 3 Insider Report for Century Therapeutics, Inc. (IPSC)

Role: Chief Executive Officer, Director
Signature: By: /s/ Michael Diem, Attorney-in-Fact
Issuer symbol: IPSC
Transactions as of: 17 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 17 Jun 2021, 16:58:38 UTC
Next filing: 27 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IPSC	Common Stock						526,839	17 Jun 2021	Direct
holding	IPSC	Common Stock						397,440	17 Jun 2021	By NS Irrevocable Trust for Gabriel O. Flores
holding	IPSC	Common Stock						397,440	17 Jun 2021	By Flores Family Trust for Gabriel O. Flores

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IPSC	Stock Option (right to buy)							17 Jun 2021	Common Stock	213,624	$1.74	Direct	F1
holding	IPSC	Stock Option (right to buy)							17 Jun 2021	Common Stock	777,417	$7.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests on the earlier of (a) the Issuer's closing of a business development transaction prior to June 30, 2021 or (b) the Issuer's closing of an initial public offering prior to August 13, 2021, in each case subject to the Reporting Person's continued service with the Issuer.
F2	The option vests 25% on the first anniversary of the closing of the Issuer's initial public offering, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.